Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 3, 2001

View Archived Issues

LION Adds Preclinical Capability Through $35M Trega Acquisition

Oxxon Plans Moves Into Phase II Following £4.7M Private Funding

New Biotechnology Center Adds Options For Israeli Start-Up Firms

Estonia Will Build National Gene Bank With SNPs Of 1M Citizens

Other News To Note

Scotia Sells Assets, Buys Time While Awaiting Foscan Decision

Germans React To British Decision On Embryonic Stem Cell Cloning

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.